SCHEMBL10264388

SCHEMBL10264388

CCC(O)CCCC(C)(C)CC=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10255580 0.88 ACACB (0.41) ACACBACACA
SCHEMBL6181190 0.82 ACACB (0.40) ACACBACACA
SCHEMBL19678193 0.81 ACACB (0.37) ACACBACACA
SCHEMBL9446083 0.81 ACACB (0.39) ACACBACACA
SCHEMBL2737933 0.79 ACACB (0.35) ACACBACACA
SCHEMBL19678179 0.79 FFAR1 (0.53) ACACBACACA
SCHEMBL19678183 0.79 ACACB (0.42) ACACBACACA
SCHEMBL19678180 0.78 ACACB (0.45) ACACBACACA
SCHEMBL8898822 0.77 ACACB (0.36) ACACBACACA
SCHEMBL19861383 0.77 ACACB (0.36) ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404890-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-11 EP disclosed